Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.
Huy Gia VuongTam N M NgoIan F DunnPublished in: Cancer medicine (2021)
Our meta-analysis demonstrated the distinct characteristics of IDH1/2-mutated chondrosarcomas in comparison to those without mutations. These mutations could serve as an independent prognostic biomarker to better prognosticate patient outcomes and design appropriate treatment plans.